Pace Alternative Strategies Fund Quote

PASIX Fund  USD 10.92  0.01  0.09%   

Performance

Very Strong

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Pace Alternative is trading at 10.92 as of the 19th of July 2025; that is 0.09% down since the beginning of the trading day. The fund's open price was 10.93. Pace Alternative has less than a 11 % chance of experiencing some financial distress in the next two years of operation and had a very strong performance during the last 90 days. The performance scores are derived for the period starting the 20th of April 2025 and ending today, the 19th of July 2025. Click here to learn more.
The fund invests in equity securities of U.S. and non-U.S. companies of various market capitalizations. It also invests in fixed income securities, which are not subject to any credit rating or maturity limitations, issued by companies and government and supranational entities around the world. More on Pace Alternative Strategies

Moving together with Pace Mutual Fund

  0.97PEVAX Pace Smallmedium ValuePairCorr
  0.93PWITX Pace International EquityPairCorr
  0.98PWTAX Ubs AllocationPairCorr
  0.98PWTYX Ubs AllocationPairCorr
  0.64PFXAX Pace Mortgage BackedPairCorr
  0.99EMPTX Ubs Emerging MarketsPairCorr

Pace Mutual Fund Highlights

Fund ConcentrationUBS Asset Management Funds, Large Value Funds, Multistrategy Funds, Multistrategy, UBS Asset Management (View all Sectors)
Update Date30th of June 2025
Fiscal Year EndJuly
Pace Alternative Strategies [PASIX] is traded in USA and was established 19th of July 2025. Pace Alternative is listed under UBS Asset Management category by Fama And French industry classification. The fund is listed under Multistrategy category and is part of UBS Asset Management family. This fund at this time has accumulated 549.09 M in assets with no minimum investment requirementsPace Alternative Str is currently producing year-to-date (YTD) return of 3.91% with the current yeild of 0.04%, while the total return for the last 3 years was 6.54%.
Check Pace Alternative Probability Of Bankruptcy

Instrument Allocation

Sector Allocation

Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on Pace Mutual Fund. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding Pace Mutual Fund, and the less return is expected.
Institutional investors that are interested in enforcing a sector tilt in their portfolio can use exchange-traded funds, such as Pace Alternative Strategies Mutual Fund, as a low-cost alternative to building a custom portfolio. So, using sector ETFs to diversify your portfolio can be a profitable strategy. However, no matter what sectors are desirable at a given time, no single industry should ever make up more than 20 percent of your stock portfolio.

Top Pace Alternative Strategies Mutual Fund Constituents

BRBroadridge Financial SolutionsStockIndustrials
MSFTMicrosoftStockInformation Technology
PFEPfizer IncStockHealth Care
GOOGLAlphabet Inc Class AStockCommunication Services
ELANElanco Animal HealthStockHealth Care
AAPLApple IncStockInformation Technology
XLKTechnology Select SectorEtfTechnology
STISolidion TechnologyStockIndustrials
More Details

Pace Alternative Str Risk Profiles

Pace Alternative Against Markets

Other Information on Investing in Pace Mutual Fund

Pace Alternative financial ratios help investors to determine whether Pace Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pace with respect to the benefits of owning Pace Alternative security.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments